Search

everythinglearnresearchcommunity

for

Search:↓

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia have lower SHBG levels.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Too much androgen can cause hair loss; finasteride may help.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride safely reduces excessive hair growth in women.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Taking biotin can lead to incorrect low results in free testosterone tests.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.